The Lazcluze plus Rybrevant combination could challenge AstraZeneca’s standard-of-care Tagrisso in non-small cell lung cancer ...

In 2024, a ransomware attack on Change Healthcare — a health payment processing company that handles an estimated 15 billion medical claims annually — shook the health care industry, impacting medical ...